- Untreated, unrecognized or poorly managed mental health issues can be a driver of substance use and can make some people vulnerable to infections such as ...
- Many people who have been living with chronic hepatitis C virus (HCV) also have other health issues, such as type 2 diabetes. In 2015, researchers at the ...
- Researchers in Brighton, England, have found that some homeless people are at increased risk for liver disease. Unfortunately, in the experience of the ...
- Researchers have found that some people with chronic hepatitis C virus (HCV) in high-income countries also have mental health and substance use issues. At least ...
- In this issue of TreatmentUpdate we discuss several emerging treatments for hepatitis C virus (HCV). Here is a brief guide to some drugs and the classes to ...
- There are limited treatment options for patients whose previous direct-acting antivirals (DAAs) have failed to cure them of chronic hepatitis C virus (HCV) ...
- People with organ transplants and hepatitis C virus (HCV) are difficult to treat because of the potential for drug-drug interactions. An advantage of ...
- Hepatitis C virus (HCV) genotype 3 does not usually respond well to therapy with previously licensed direct-acting antivirals (DAAs). Therapy for this strain of ...
- Most people with chronic hepatitis C virus (HCV) infection will likely be cured when they take modern all-oral treatments (otherwise known as direct-acting ...
- In a study called Polaris-4, researchers enrolled participants whose previous regimen(s) of direct-acting antivirals (DAAs) had failed to cure them. Researchers ...
- In late June 2017, Health Canada licensed the sale and use of a new formulation of the anti-HIV drug raltegravir (Isentress) as part of the treatment of HIV. ...
- In a two-year trial called Oncemrk, researchers in Canada and other countries compared a regimen containing the older formulation of raltegravir (Isentress) to ...